ResearcherCentral South UniversityActive in the last 2 years

Shun Deng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5070079148. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.isci.2025.113053 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Biaoming Xu · 1 shared paper, 2025 · strength 0.25
- Paper Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113053 ↗
Chaohui Zuo · 1 shared paper, 2025 · strength 0.25
- Paper Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113053 ↗
Wenzhi Tan · 1 shared paper, 2025 · strength 0.25
- Paper Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma. DOI 10.1016/j.isci.2025.113053 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.